CAAS Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-143,000
Closed -$1.44M 974
2022
Q4
$1.44M Hold
143,000
0.09% 234
2022
Q3
$1.4M Hold
143,000
0.07% 323
2022
Q2
$1.4M Hold
143,000
0.07% 315
2022
Q1
$1.4M Buy
143,000
+20,300
+17% +$197K 0.06% 259
2021
Q4
$1.2M Hold
122,700
0.03% 414
2021
Q3
$1.19M Buy
+122,700
New +$1.19M 0.02% 451

Other funds holding AONC

CAAS Capital Management's AONC Position: Q1 2023 in Review

CAAS Capital Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 143,000 shares — an estimated $1.44M sold.

CAAS Capital Management first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $1.44M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • CAAS Capital Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • CAAS Capital Management sold 143,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.44M.
  • CAAS Capital Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
  • CAAS Capital Management's American Oncology Network, Inc. Class A Common Stock position peaked at $1.44M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on CAAS Capital Management's 13F filing for Q1 2023, filed 15 May 2023.